menu search

LBPH / Longboard Pharmaceuticals, Inc. (LBPH) is on the Move, Here's Why the Trend Could be Sustainable

Longboard Pharmaceuticals, Inc. (LBPH) is on the Move, Here's Why the Trend Could be Sustainable
Longboard Pharmaceuticals, Inc. (LBPH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen. Read More
Posted: May 1 2023, 09:55
Author Name: Zacks Investment Research
Views: 110289

LBPH News  

Longboard Pharmaceuticals, Inc. (LBPH) is on the Move, Here's Why the Trend Could be Sustainable

By Zacks Investment Research
May 1, 2023

Longboard Pharmaceuticals, Inc. (LBPH) is on the Move, Here's Why the Trend Could be Sustainable

Longboard Pharmaceuticals, Inc. (LBPH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundament more_horizontal

Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why

By Zacks Investment Research
April 14, 2023

Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why

Longboard Pharmaceuticals, Inc. (LBPH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a more_horizontal

Does Longboard Pharmaceuticals, Inc. (LBPH) Have the Potential to Rally 208.22% as Wall Street Analysts Expect?

By Zacks Investment Research
April 7, 2023

Does Longboard Pharmaceuticals, Inc. (LBPH) Have the Potential to Rally 208.22% as Wall Street Analysts Expect?

The mean of analysts' price targets for Longboard Pharmaceuticals, Inc. (LBPH) points to a 208.2% upside in the stock. While this highly sought-after more_horizontal

Longboard Pharmaceuticals, Inc. (LBPH) Q4 2022 Results - Earnings Call Transcript

By Seeking Alpha
March 2, 2023

Longboard Pharmaceuticals, Inc. (LBPH) Q4 2022 Results - Earnings Call Transcript

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH ) Q4 2022 Results Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants Brandi Roberts - more_horizontal

Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023

By Business Wire
February 23, 2023

Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023

SAN DIEGO--(BUSINESS WIRE)---- $LBPH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on more_horizontal

Longboard Pharmaceuticals: Arena Team's Next Act Is Flying Under The Radar

By Seeking Alpha
November 23, 2022

Longboard Pharmaceuticals: Arena Team's Next Act Is Flying Under The Radar

Shares have fallen by nearly 70% since IPO. Leadership including President & CEO hails from Arena Pharmaceuticals (bought out by Pfizer for $6.7B last more_horizontal

Longboard Pharmaceuticals to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference

By GlobeNewsWire
August 3, 2022

Longboard Pharmaceuticals to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference

SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on dev more_horizontal


Search within

Pages Search Results: